The Supreme Court won’t take up drugmakers’ IRA cases
The Supreme Court says it won’t wade into the pharma industry’s yearslong legal battle over Medicare drug price negotiations. The justices declined to review multiple cases brought by AstraZeneca, J&J, Bristol Myers Squibb, Novo Nordisk and Boehringer Ingelheim.